|
⚲
|
| Keyboard |
| McFarlane Neil F
✚
|
|
|---|---|
| CIK # | 0001681098 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001681098] | |
| 4 | [0001681098] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| McFarlane Neil F | |
| Zevra Therapeutics Inc | |
| Collegium Pharmaceutical Inc | |
| Adamas Pharmaceuticals Inc | |
| Travere Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Zevra Therapeutics Inc ZVRA
Common Stock
|
2026-02-09 | Sell | 14,625 | $8.56 | 125,190 |
|
Zevra Therapeutics Inc ZVRA
Restricted Stock Unit · derivative
|
2026-02-07 | Option exercise | 37,500 | $0.00 | |
|
Zevra Therapeutics Inc ZVRA
Common Stock
|
2026-02-07 | Option exercise | 37,500 | ||
|
Zevra Therapeutics Inc ZVRA
Common Stock
|
2026-02-02 | Sell | 91,000 | $9.38 | 853,580 |
|
Zevra Therapeutics Inc ZVRA
Restricted Stock Unit · derivative
|
2026-01-31 | Option exercise | 233,334 | $0.00 | |
|
Zevra Therapeutics Inc ZVRA
Common Stock
|
2026-01-31 | Option exercise | 233,334 | ||
|
Zevra Therapeutics Inc ZVRA
Stock Option (right to buy) · derivative
|
2026-01-29 | Grant | 250,000 | $0.00 | |
|
Zevra Therapeutics Inc ZVRA
Restricted Stock Unit · derivative
|
2026-01-29 | Grant | 125,000 | $0.00 | |
|
Zevra Therapeutics Inc ZVRA
Restricted Stock Unit · derivative
|
2025-10-10 | Option exercise | 50,000 | $0.00 | |
|
Zevra Therapeutics Inc ZVRA
Common Stock
|
2025-10-10 | Option exercise | 50,000 | ||
|
Zevra Therapeutics Inc ZVRA
Common Stock
|
2025-10-10 | Sell | 19,500 | $10.82 | 210,990 |
|
Zevra Therapeutics Inc ZVRA
Common Stock
|
2025-02-14 | Sell | 30,544 | $8.05 | 245,879 |
|
Zevra Therapeutics Inc ZVRA
Common Stock
|
2025-02-13 | Sell | 61,273 | $7.86 | 481,606 |
|
Zevra Therapeutics Inc ZVRA
Restricted Stock Unit · derivative
|
2025-02-07 | Grant | 112,500 | $0.00 | |
|
Zevra Therapeutics Inc ZVRA
Stock Option (right to buy) · derivative
|
2025-02-07 | Grant | 225,000 | $0.00 | |
|
Zevra Therapeutics Inc ZVRA
Common Stock
|
2025-01-31 | Option exercise | 233,333 | ||
|
Zevra Therapeutics Inc ZVRA
Restricted Stock Unit · derivative
|
2025-01-31 | Option exercise | 233,333 | $0.00 | |
|
Collegium Pharmaceutical Inc COLL
Common Stock
|
2024-05-16 | Grant | 7,693 | $0.00 | |
|
Zevra Therapeutics Inc ZVRA
Restricted Stock Unit · derivative
|
2024-01-31 | Grant | 700,000 | $0.00 | |
|
Zevra Therapeutics Inc ZVRA
Stock Option (right to buy) · derivative
|
2023-10-10 | Grant | 600,000 | $0.00 | |
| showing 20 of 49 most recent transactions | |||||